Using the ORAI1 E106Q pore dead mutant and L273D STIM1 binding-deficient mutant, our study demonstrated that ORAI1 regulation of PTGS2 and IL6 expression in basal breast cancer is dependent on both ORAI1 pore activity and STIM1 binding. Here, PTGS2 is linked to breast cancer.